Goodvastatin CV 10 Tablet is a combination pharmaceutical formulation containing Atorvastatin 10 mg and Clopidogrel 75 mg, designed for the management of cardiovascular conditions. Atorvastatin, a potent HMG-CoA reductase inhibitor, effectively reduces low-density lipoprotein cholesterol (LDL-C) and total cholesterol levels, thereby lowering the risk of atherosclerosis and associated cardiovascular events. Clopidogrel, an antiplatelet agent, inhibits platelet aggregation by selectively and irreversibly blocking the P2Y12 adenosine diphosphate (ADP) receptor on platelets, thus preventing thrombus formation. This dual-action therapy is indicated for patients at high risk of cardiovascular events, including those with a history of myocardial infarction, stroke, or established peripheral arterial disease. Goodvastatin CV 10 Tablet aids in secondary prevention by addressing both lipid abnormalities and platelet-mediated thrombosis, thereby reducing the incidence of major adverse cardiovascular events. The combination improves patient compliance by minimizing pill burden. It is essential to use this medication under medical supervision, considering potential contraindications such as active bleeding, liver dysfunction, or hypersensitivity to either component. Regular monitoring of lipid profiles, liver enzymes, and bleeding parameters is recommended during therapy to ensure efficacy and safety.